(Q44398113)

English

Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails

scientific article published in May 2003

In more languages
default values for all languages
No label defined

No description defined

Statements

Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit